Glesatinib

Product Specifications

CAS Number

936694-12-1

Synonyms

MGCD265

Target

C-Met

Applications

Protein Tyrosine Kinase

Molecular Formula

C31H27F2N5O3S2

Additionnal Information

Glesatinib (MGCD265) is an orally bioavailable potent dual inhibitor of c-MET and SMO. Glesatinib counteracts P-glycoprotein (P-gp) mediated multidrug resistance (MDR) in non-small cell lung cancer (NSCLC) .

More Discoveries

Explore Other Products

Browse additional items from our catalog

70R-31497 100 ug

NPM antibody

View Details

SL2264Hu-01 48 Tests

Human Meprin A Alpha (MEP1a) ELISA Kit

View Details

SL2264Hu-02 96 Tests

Human Meprin A Alpha (MEP1a) ELISA Kit

View Details

AMM21649VCF 100 µg

GFAP Mouse Monoclonal Antibody [Clone ID: LBI11A2]

View Details

248642-ML650 100 µL

MEF2A (Myocyte Enhancer Factor 2A, ADCAD1, RSRFC4, RSRFC9) (MaxLight 650)

View Details

TA809382 100 µL

RAB23 Mouse Monoclonal Antibody [Clone ID: OTI1A3]

View Details